Phase 1 Single Dose Escalation Study of CTB-001
Clinical trial NCT01647893 · UNKNOWN
Trial details
- NCT number
- NCT01647893
- Sponsor
- HLB Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.